181 related articles for article (PubMed ID: 30555635)
1. Diagnostic performance of Gd-EOB-DTPA-enhanced MRI for evaluation of liver dysfunction: a multivariable analysis of 3T MRI sequences.
Verloh N; Utpatel K; Zeman F; Fellner C; Schlitt HJ; Müller M; Stroszczynski C; Evert M; Wiggermann P; Haimerl M
Oncotarget; 2018 Nov; 9(91):36371-36378. PubMed ID: 30555635
[TBL] [Abstract][Full Text] [Related]
2. Assessing liver function by liver enhancement during the hepatobiliary phase with Gd-EOB-DTPA-enhanced MRI at 3 Tesla.
Verloh N; Haimerl M; Zeman F; Schlabeck M; Barreiros A; Loss M; Schreyer AG; Stroszczynski C; Fellner C; Wiggermann P
Eur Radiol; 2014 May; 24(5):1013-9. PubMed ID: 24531844
[TBL] [Abstract][Full Text] [Related]
3. Assessing liver function: diagnostic efficacy of parenchymal enhancement and liver volume ratio of Gd-EOB-DTPA-enhanced MRI study during interstitial and hepatobiliary phase.
Ippolito D; Pecorelli A; Famularo S; Bernasconi D; Orsini EB; Giani A; Romano F; Talei Franzesi C; Sironi S
Abdom Radiol (NY); 2019 Apr; 44(4):1340-1349. PubMed ID: 30411177
[TBL] [Abstract][Full Text] [Related]
4. Gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid-enhanced magnetic resonance imaging for evaluating fibrosis regression in chronic hepatitis C patients after direct-acting antiviral.
Li XH; Huang R; Yang M; Wang J; Gao YH; Jin Q; Ma DL; Wei L; Rao HY
World J Gastroenterol; 2022 May; 28(20):2214-2226. PubMed ID: 35721884
[TBL] [Abstract][Full Text] [Related]
5. MRI-based estimation of liver function: Gd-EOB-DTPA-enhanced T1 relaxometry of 3T vs. the MELD score.
Haimerl M; Verloh N; Fellner C; Zeman F; Teufel A; Fichtner-Feigl S; Schreyer AG; Stroszczynski C; Wiggermann P
Sci Rep; 2014 Jul; 4():5621. PubMed ID: 25001391
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic performance and description of morphological features of focal nodular hyperplasia in Gd-EOB-DTPA-enhanced liver magnetic resonance imaging: results of a multicenter trial.
Zech CJ; Grazioli L; Breuer J; Reiser MF; Schoenberg SO
Invest Radiol; 2008 Jul; 43(7):504-11. PubMed ID: 18580333
[TBL] [Abstract][Full Text] [Related]
7. Correlation of histologic, imaging, and artificial intelligence features in NAFLD patients, derived from Gd-EOB-DTPA-enhanced MRI: a proof-of-concept study.
Bastati N; Perkonigg M; Sobotka D; Poetter-Lang S; Fragner R; Beer A; Messner A; Watzenboeck M; Pochepnia S; Kittinger J; Herold A; Kristic A; Hodge JC; Traussnig S; Trauner M; Ba-Ssalamah A; Langs G
Eur Radiol; 2023 Nov; 33(11):7729-7743. PubMed ID: 37358613
[TBL] [Abstract][Full Text] [Related]
8. Gd-EOB-DTPA Enhanced MRI Features of Liver Hemangiomatosis Coexistent with GCH.
Liu D; Qiao Z; Xu L; Fu F; Ye A; Hu C
Curr Med Imaging; 2022; 18(13):1390-1395. PubMed ID: 35657047
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a predictor of insufficient enhancement during the hepatobiliary phase of Gd-EOB-DTPA-enhanced magnetic resonance imaging.
Cui E; Long W; Luo L; Hu M; Huang L; Chen X
Acta Radiol; 2017 Oct; 58(10):1174-1181. PubMed ID: 28090793
[TBL] [Abstract][Full Text] [Related]
10. Gd-EOB-DTPA-enhanced MRI for evaluation of liver function: Comparison between signal-intensity-based indices and T1 relaxometry.
Haimerl M; Verloh N; Zeman F; Fellner C; Nickel D; Lang SA; Teufel A; Stroszczynski C; Wiggermann P
Sci Rep; 2017 Mar; 7():43347. PubMed ID: 28266528
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of liver parenchymal enhancement and liver volume to standard liver volume ratio on Gd-EOB-DTPA-enhanced MRI for estimation of liver function.
Yoneyama T; Fukukura Y; Kamimura K; Takumi K; Umanodan A; Ueno S; Nakajo M
Eur Radiol; 2014 Apr; 24(4):857-65. PubMed ID: 24356768
[TBL] [Abstract][Full Text] [Related]
12. Assessing liver function in patients with HBV-related HCC: a comparison of T₁ mapping on Gd-EOB-DTPA-enhanced MR imaging with DWI.
Ding Y; Rao SX; Chen C; Li R; Zeng MS
Eur Radiol; 2015 May; 25(5):1392-8. PubMed ID: 25523455
[TBL] [Abstract][Full Text] [Related]
13. T
Yang L; Ding Y; Rao S; Chen C; Zeng M
J Magn Reson Imaging; 2021 Mar; 53(3):896-902. PubMed ID: 32979019
[TBL] [Abstract][Full Text] [Related]
14. Clinical factors predictive of insufficient liver enhancement on the hepatocyte-phase of Gd-EOB-DTPA-enhanced magnetic resonance imaging in patients with liver cirrhosis.
Kim HY; Choi JY; Park CH; Song MJ; Song DS; Kim CW; Bae SH; Yoon SK; Lee YJ; Rha SE
J Gastroenterol; 2013 Oct; 48(10):1180-7. PubMed ID: 23354621
[TBL] [Abstract][Full Text] [Related]
15. Quantitative evaluation of liver function with T1 relaxation time index on Gd-EOB-DTPA-enhanced MRI: comparison with signal intensity-based indices.
Kamimura K; Fukukura Y; Yoneyama T; Takumi K; Tateyama A; Umanodan A; Shindo T; Kumagae Y; Ueno S; Koriyama C; Nakajo M
J Magn Reson Imaging; 2014 Oct; 40(4):884-9. PubMed ID: 24677659
[TBL] [Abstract][Full Text] [Related]
16. Application Progress of Gd-EOB-DTPA-Enhanced MRI T1 Mapping in Hepatic Diffuse Diseases.
Wen X; Feng X; Kang Y; Xu L
Curr Med Imaging; 2022; 18(12):1276-1281. PubMed ID: 34847846
[TBL] [Abstract][Full Text] [Related]
17. Evaluating segmental liver function using T1 mapping on Gd-EOB-DTPA-enhanced MRI with a 3.0 Tesla.
Zhou ZP; Long LL; Qiu WJ; Cheng G; Huang LJ; Yang TF; Huang ZK
BMC Med Imaging; 2017 Mar; 17(1):20. PubMed ID: 28249571
[TBL] [Abstract][Full Text] [Related]
18. Assessment of clinical signs of liver cirrhosis using T1 mapping on Gd-EOB-DTPA-enhanced 3T MRI.
Haimerl M; Verloh N; Zeman F; Fellner C; Müller-Wille R; Schreyer AG; Stroszczynski C; Wiggermann P
PLoS One; 2013; 8(12):e85658. PubMed ID: 24392025
[TBL] [Abstract][Full Text] [Related]
19. Gd-EOB-DTPA-enhanced magnetic resonance imaging features of hepatic hemangioma compared with enhanced computed tomography.
Tateyama A; Fukukura Y; Takumi K; Shindo T; Kumagae Y; Kamimura K; Nakajo M
World J Gastroenterol; 2012 Nov; 18(43):6269-76. PubMed ID: 23180948
[TBL] [Abstract][Full Text] [Related]
20. Dynamic-contrast-enhanced magnetic resonance imaging of cirrhotic liver parenchyma: A comparison between gadolinium-diethylenetriamine pentaacetic acid and gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid.
Lin CY; Chang WC; Chou CT; Chen RC
J Chin Med Assoc; 2015 Nov; 78(11):666-72. PubMed ID: 26341453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
